Fécondation in vitro: intérêt et désavantage du remboursement par l'assurance maladie en Suisse [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland]

Détails

ID Serval
serval:BIB_59728BD98A3F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Fécondation in vitro: intérêt et désavantage du remboursement par l'assurance maladie en Suisse [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland]
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Wunder-Galié D., Hohlfeld P., de Ziegler D.
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2009
Volume
5
Numéro
222
Pages
2106-2108, 2110
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/CSI by the health insurance in Switzerland The reimbursement of certain infertility treatments (stimulation with/without insemination) whereas IVF/ICSI is not leads patients with an indication of IVF to prefer treatments of low efficacy. The costs of multiple pregnancies issued by reimbursed or non-reimbursed fertility treatments are paid by the society. There should be measures to reduce these costs and to take the money used today to pay the complications of infertility treatments to reimburse IVF. The efficacy of such a system (single embryo transfer) has been proven in Belgium since several years. The dangers of complete reimbursement (IVF treatment in cases without any chances of success, only because it is for free) can be avoided by an Efficacy and Safety Board.
Mots-clé
Fertilization in Vitro/economics, Humans, Insurance Coverage, Reimbursement Mechanisms, Reproductive Techniques, Assisted/economics, Switzerland
Pubmed
Création de la notice
15/02/2010 22:55
Dernière modification de la notice
20/08/2019 15:12
Données d'usage